Table 2. | Expression of laminin-332 γ2 chain and MMP-9 |
| Expression |
High risk oral lesion (n = 10) |
OSCC (n = 26) |
P-value |
|---|---|---|---|
| Laminin-332 γ2 in basement membrane | |||
| Continuous | 60% (n = 6) | 0 | 0.000a |
| Discontinuous | 40% (n = 4) | 69.2% (n = 18) | |
| Absence | 0 | 30.8% (n = 8) | |
| Laminin-332 γ2 in epithelium | |||
| BL | 10% (n = 1) | 35% (n = 7) | 0.2103 |
| BL+SL | 90% (n=9) | 65% (n = 13) | |
| MMP-9 in epithelium | |||
| BL | 50% (n = 5) | 35% (n = 7) | 0.4072 |
| SL | 30% (n = 3) | 20% (n = 4) | |
| BL+SL | 20% (n = 2) | 45% (n = 9) | |
| MMP-9 stroma/field | |||
| < 25% cells/field | 40% (n = 4) | 11,5% (n = 3) | 0.0086a |
| 25 - 50% cells/field | 50% (n = 5) | 15,4% (n = 4) | |
| > 50% cells/field | 10% (n = 1) | 73.1% (n = 19) | |
aChi-square test (significance level P < 0.05).
|
.png)